Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotics Weight Gain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00903916
What this trial is testing

Effect of Antipsychotics on Appetite Regulation

Who this might be right for
Psychotic Disorders
University of North Carolina, Chapel Hill 45
Post-approval studies (Phase 4)Looking for participantsNCT05744479
What this trial is testing

Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability

Who this might be right for
Intellectual DisabilityDevelopmental DisabilityObesity
Centre for Addiction and Mental Health 100
Large-scale testing (Phase 3)Looking for participantsNCT06936137
What this trial is testing

: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)

Who this might be right for
Antipsychotic Induced Weight Gain
Ain Shams University 180
Not applicableStudy completedNCT01866098
What this trial is testing

Naltrexone for Antipsychotic-Induced Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Yale University 144
Not applicableUnknownNCT00627757
What this trial is testing

Antipsychotic Medicine and Metabolic Syndrome

Who this might be right for
Metabolic Syndrome
Glostrup University Hospital, Copenhagen 100
Not applicableLooking for participantsNCT07817069
What this trial is testing

Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects

Who this might be right for
Treatment Resistant SchizophreniaObesity & OverweightAbdominal Obesity
Faculty of Medicine, Sousse 30
Not applicableStudy completedNCT00474227
What this trial is testing

Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness

Who this might be right for
Obesity
Lev-Hasharon Mental Healtlh Center 50
Testing effectiveness (Phase 2)Study completedNCT00709202
What this trial is testing

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+5 more
Nathan Kline Institute for Psychiatric Research 48
Early research (Phase 1)Study completedNCT01231074
What this trial is testing

Reducing Antipsychotic-Induced Weight Gain in Children With Metformin

Who this might be right for
ObesityWeight GainPsychotropic Induced Weight Gain
Nationwide Children's Hospital 96
Post-approval studies (Phase 4)Study completedNCT00148564
What this trial is testing

Energy Homeostasis Under Treatment With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Charite University, Berlin, Germany 40
Post-approval studies (Phase 4)Ended earlyNCT01844700
What this trial is testing

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

Who this might be right for
High Risk MC4R GenotypeLow Risk MC4R GenotypeOne Week or Less Antipsychotic Lifetime Exposure
Northwell Health 14
Not applicableStudy completedNCT00169702
What this trial is testing

The Effect of a Weight Management Program During Treatment With Olanzapine

Who this might be right for
Schizophrenia
Heinrich-Heine University, Duesseldorf 100
Not applicableStudy completedNCT01075295
What this trial is testing

Prevention of Weight Gain in Early Psychoses

Who this might be right for
Schizophreniform DisorderBipolar I DisorderBipolar II Disorder+5 more
Centre for Addiction and Mental Health 70
Early research (Phase 1)Study completedNCT05712265
What this trial is testing

Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Who this might be right for
Antipsychotic Induced Weight GainNon-alcoholic Steatohepatitis (NASH)
Corcept Therapeutics 26
Not applicableStudy completedNCT02281162
What this trial is testing

The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain

Who this might be right for
SchizophreniaMetabolic SyndromeVitamin D Deficiency
Creighton University 20
Not applicableLooking for participantsNCT06729671
What this trial is testing

A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

Who this might be right for
Psychosis
University College Cork 70
Not applicableStudy completedNCT00363181
What this trial is testing

Side Effects of Antipsychotic Medications

Who this might be right for
Insulin ResistanceMetabolic Syndrome XSchizophrenia and Disorders With Psychotic Features+2 more
Stanford University 76
Post-approval studies (Phase 4)UnknownNCT00182494
What this trial is testing

Diabetes Prevention Program in Schizophrenia [DPPS]

Who this might be right for
Diabetes MellitusSchizophrenia
Hamilton Health Sciences Corporation 200
Post-approval studies (Phase 4)Study completedNCT00191828
What this trial is testing

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Who this might be right for
Weight Gain
Eli Lilly and Company 60
Post-approval studies (Phase 4)UnknownNCT00541554
What this trial is testing

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Who this might be right for
HyperprolactinemiaWeight GainDyslipidemia
Genovate Biotechnology Co., Ltd.,
Next Page